AMIC accelerator technology looks positive for Mo-99 production
Advanced Medical Isotope Corporation (AMIC) has achieved "encouraging results" from initial tests of its accelerator technology for the domestic production of molybdenum-99 (Mo-99).

AMIC is conducting the tests at Idaho State University in Pocatello, Idaho, in conjunction with researchers from the University of Missouri in Columbia, Mo.

The technology is expected to be able to capture a significant portion of the U.S. domestic market, and will employ low-enriched uranium, according to James C. Katzaroff, CEO of AMIC. He added that the first production facility would most likely be in either Washington or Idaho and would take a much shorter time to build than comparable reactor systems.